Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M G Zagorski

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Idrugs : the Investigational Drugs Journal|May 10, 2008
Amyloid aggregation inhibitorsM G Zagorski
Biochemistry|June 23, 1992
NMR studies of amyloid beta-peptides: proton assignments, secondary structure, and mechanism of an alpha-helix----beta-sheet conversion for a homologous, 28-residue, N-terminal fragmentM G Zagorski, C J Barrow
Science (New York, N.Y.)|July 12, 1991
Solution structures of beta peptide and its constituent fragments: relation to amyloid depositionC J Barrow, M G Zagorski
Biochemical and Biophysical Research Communications|April 30, 1992
Covalent modification of Alzheimer's amyloid beta-peptide in formic acid solutionsR Orlando, P T Kenny, M G Zagorski
Journal of Molecular Biology|January 8, 1999
Solution structures of micelle-bound amyloid beta-(1-40) and beta-(1-42) peptides of Alzheimer's diseaseH Shao, S Jao, K Ma, et al.
Biochemistry|June 28, 1994
Solution structure of residues 1-28 of the amyloid beta-peptideJ Talafous, K J Marcinowski, G Klopman, et al.
Journal of Molecular Biology|June 20, 1992
Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectraC J Barrow, A Yasuda, P T Kenny, et al.
Journal of the American Chemical Society|January 31, 2012
Biosynthetic origins and assignments of carbon 13 NMR peaks of brevetoxin BM S Lee, D J Repeta, K Nakanishi, et al.
Biochemistry|October 22, 1996
Nicotine inhibits amyloid formation by the beta-peptideA R Salomon, K J Marcinowski, R P Friedland, et al.
Methods in Enzymology|October 3, 1999
Methodological and chemical factors affecting amyloid beta peptide amyloidogenicityM G Zagorski, J Yang, H Shao, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Idrugs : the Investigational Drugs Journal|May 10, 2008
Amyloid aggregation inhibitorsM G Zagorski
Biochemistry|June 23, 1992
NMR studies of amyloid beta-peptides: proton assignments, secondary structure, and mechanism of an alpha-helix----beta-sheet conversion for a homologous, 28-residue, N-terminal fragmentM G Zagorski, C J Barrow
Science (New York, N.Y.)|July 12, 1991
Solution structures of beta peptide and its constituent fragments: relation to amyloid depositionC J Barrow, M G Zagorski
Biochemical and Biophysical Research Communications|April 30, 1992
Covalent modification of Alzheimer's amyloid beta-peptide in formic acid solutionsR Orlando, P T Kenny, M G Zagorski
Journal of Molecular Biology|January 8, 1999
Solution structures of micelle-bound amyloid beta-(1-40) and beta-(1-42) peptides of Alzheimer's diseaseH Shao, S Jao, K Ma, et al.
Biochemistry|June 28, 1994
Solution structure of residues 1-28 of the amyloid beta-peptideJ Talafous, K J Marcinowski, G Klopman, et al.
Journal of Molecular Biology|June 20, 1992
Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectraC J Barrow, A Yasuda, P T Kenny, et al.
Journal of the American Chemical Society|January 31, 2012
Biosynthetic origins and assignments of carbon 13 NMR peaks of brevetoxin BM S Lee, D J Repeta, K Nakanishi, et al.
Biochemistry|October 22, 1996
Nicotine inhibits amyloid formation by the beta-peptideA R Salomon, K J Marcinowski, R P Friedland, et al.
Methods in Enzymology|October 3, 1999
Methodological and chemical factors affecting amyloid beta peptide amyloidogenicityM G Zagorski, J Yang, H Shao, et al.
Pageof 2